Bobby Axelrod

Bobby Axelrod

reporting the latest news globally

Showing 31 to 40 of 106 news articles
LVMH headquarters showcases luxury brands amidst market uncertainty. image
Headlines

LVMH Misses Expectations Luxury Market Wobbles

The Strait of Hormuz, a critical chokepoint for global oil supply, now under US blockade intensifying market volatility. image
World News

Trump's Strait of Hormuz Blockade Shocks Oil Markets

Europe faces mounting pressure to revitalize its pharmaceutical sector amidst rising global competition and shifting investment landscapes. Time to ante up or get out. image
Health Care

Europe's Pharma Decline A Wake-Up Call for Global Competitiveness

Private jets line up at Augusta Regional Airport during the Masters Tournament, showcasing the event's significance in the private aviation industry. image
Business

Masters of the Skies Private Jet Firms Battle for Elite Clients

Generic weight-loss drugs surge in India, challenging the dominance of established players like Eli Lilly and Novo Nordisk. image
Headlines

Eli Lilly's Weight-Loss Empire Faces Generic Onslaught in India

Gold bars and coins a tangible hedge against market volatility, a Bobby Axelrod approved investment. image
Headlines

Gold Rush The Modern Day Midas Touch

The Strait of Hormuz, a critical chokepoint for global oil supply, caught in a geopolitical tug-of-war, reminiscent of a leveraged buyout gone sour.  image
US News

Strait of Hormuz Gridlock A Real Estate Play Gone Wrong

AI is changing the game for fashion retailers by offering virtual try-on solutions to minimize returns and enhance the shopping experience. image
Headlines

AI's Fashion Fix: Can Tech Tame the Trillion-Dollar Returns Monster?

Construction continues at the White House despite legal challenges to President Trump's proposed ballroom addition. image
Headlines

Trump's White House Ballroom Dreams Face Legal Scrutiny

Trump's tariff threats could reshape the pharmaceutical industry landscape, incentivizing domestic drug production and deal-making. image
World News

Trump's Tariff Gambit Big Pharma Gets the Axe?